SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments
  • David, thank you for the note. It appears there is... »
  • The link to the US proposal seems to be broken, an... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    ACTA Risks Long-Term Damage To Democratic Public Policymaking, NGOs Say

    Published on 30 June 2010 @ 11:02 pm

    By and for Intellectual Property Watch

    An international agreement on intellectual property rights enforcement now under negotiation in Lucerne, Switzerland runs the risk of ushering in a new and undemocratic precedent for international policymaking that could have long-term damaging effects on critical public policy issues, non-negotiating government representatives and civil society advocates said this week.

    The Anti-Counterfeiting Trade Agreement, they said, could have a chilling effect on access to medications, including the potential to criminalise makers of active pharmaceutical ingredients who are critical to the generics industry, and could cause serious problems for internet freedom.

    The 28 June event in Geneva was cosponsored by Knowledge Ecology International and IQsensato.

    More worrying, they added, is that while currently an initiative of a few countries, its ultimate aim seems to be to become universal. The negotiating process seems to follow on the heels of the trend of countries shopping for easy fora through which to push the same increasing intellectual property enforcement agenda. Denied enforcement actions in places such as the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO), the World Customs Organization and elsewhere, these countries are now creating their own forum under ACTA.

    This platform can then be used to foist burdensome enforcement strategies on the rest of the world through bilateral and regional agreements. If such a strategy is allowed to succeed, they argue, it could have follow-on effects far outside the intellectual property sphere.

    While it is probably too late to stop, the ACTA could be saved if its real targets act, said Michael Geist, a professor at the University of Ottawa and a staunch critic of the ACTA process to date.

    At the “end of the day, ACTA is about Brazil, India” and other emerging economies, Geist said. If those countries “who are the targets [and] who have for too long sat on the sidelines and said they weren’t part of the process … are willing to stand up and be more aggressive,” then ACTA could be turned into something that would not risk upsetting a balanced IP regime.

    ACTA’s ninth negotiating session is taking place in this week in Lucerne, Switzerland.

    Negotiators in Lucerne on Monday met with nongovernmental organisations and later the Pirate Party. For one and a half hours the Berne Declaration and several other nongovernmental organisations presented their concerns to the delegations of Australia, Canada, European Union, Japan, Mexico, Morocco, New Zealand, Singapore, Switzerland, and the United States who are negotiating the agreement.

    From Forum Shopping to Forum Creation

    ACTA is only a piece of the story in the long conflict between developing and developed countries over IP issues, Zhao Hong of the mission of China, speaking in her personal capacity and not on behalf of the Chinese government, told Monday’s NGO event in Geneva. China and India at the last meeting of the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council (IPW, 3 June 2010, WTO/TRIPS).

    There were attempts at norm-setting on enforcement measures made within the WTO and WIPO where members refused, said Viviana Muñoz Tellez of the South Centre, also speaking on her own behalf.

    Free trade agreements were a way to circumvent that refusal, she said. And once ACTA is in place, “what we’re likely to see is ACTA being pushed on developing countries … through the route of FTAs,” said Muñoz. There will be more bilateral agreements that will include reference to ACTA or its parts, in the same way that current FTAs often reference the TRIPS agreement, but call for reduced flexibilities or transition periods, she predicted.

    But ACTA represents a significant threat that extends well beyond just the IP enforcement issues, said Geist. The move to create an institutional structure around the agreement with oversight structure that those not currently party to could later be pressured to join creates a series of threats down the line to initiatives such as the Development Agenda at WIPO, he said.

    “If you see enforcement as a key goal and you can achieve it outside of WIPO you have very little incentive to negotiate in good faith,” Geist said.

    If ACTA is successful, the message is that creating a “coalition of the willing” outside the UN institutions (which bring some kind of transparency) is “why bother” with the UN institutions if a plurilateral process can achieve better successes faster and then be held out as part of the price of admission to later trade deals, said Geist.

    ACTA, Internet, Public Health

    There are also concerns with the text of the agreement.

    The internet enforcement chapter risks being “WIPO-plus,” said Geist – seeking to “roll back the clock” on standards that in the mid-1990s WIPO rejected in order to reach consensus with two major agreements over behaviour online. Proposed text in ACTA on injunctions risks limiting critical flexibilities in current international laws that allow for balance between the interests of rights holders and the interests of the public and of industries who depend on certain technologies, said James Love, president of Knowledge Ecology International.

    The concept of intermediary liability – in which internet service providers could be held responsible for the activities of their users – is of great concern to internet service providers and those concerned with freedom online, said several speakers.

    Intermediary liability also may be of concern to active pharmaceutical ingredient makers whose products may be used downstream in counterfeit or infringing drugs, said James Love, director of KEI. Uncertainty about liability for intellectual property infringements down the line may deter manufacturers of legitimate chemicals from selling to legitimate generic drug manufacturers, Love said later.

    Proposed ACTA customs provisions too are problematic, said Argentinian academic Carlos Correa. Some would allow “customs authorities to act upon their initiative in suspending goods suspected of infringing an IP right” – including patent rights, which are difficult to tell by sight – and could create barriers to trade in products even if protected neither in the country of import or export, he said. This can encourage abuses by rights holders, and has already created concern among generic medicine producers in India and Brazil and Ecuador, who have an ongoing discussion at the WTO dispute settlement body over a European customs law that does the same thing.

    ACTA Negotiators Meet NGOs

    “We were told that there was a growing consensus that patents would be taken out of border measures at least, but we still see potential problems for the trade in generic drugs as long as seizures might be based on confusingly similar marks,” said Patrick Durisch from the Berne Declaration, speaking to the ACTA negotiators.

    One other major change that would be a problem according to Durisch was that not only the law of the import country, but also the law of the transit country would become applicable with ACTA.

    “For us the meeting felt a little bit like a tribunal,” said Stephan Urbach, ACTA coordinator of the Pirate Party Germany, after a meeting of the Pirate Party representatives from Switzerland, Austria and Germany with the ACTA negotiators. Their critique about the lack of transparency of the negotiations so far was rejected vehemently by the lead EU negotiator who said that “everything” had been published. The three Pirate parties presented the ACTA negotiators with a Stop-ACTA petition signed by 4,400 people from all over the world. Urbach said he hoped in the future that the anti-ACTA movement would unite.

    Yet there are ACTA critics who think changes might save the agreement. A new draft version of ACTA that would do was just presented for example by several US library associations, the Center for Democracy and Technology, Public Knowledge and several industry and consumer associations. They propose to focus ACTA much more on counterfeiting, include limitations and exemptions and re-write the internet chapter.

    Kaitlin Mara may be reached at kmara@ip-watch.ch.

    Monika Ermert may be reached at info@ip-watch.ch.

     

    Comments

    1. James Love says:

      On the issue of third party liability, our concern is that uncertainty about liability for infringement of intellectual property rights may deter manufacturers of legitimate chemicals from selling to legitimate generic drug manufacturers.

      Measures to protect consumers from unsafe drugs are an important, but different issue. Willful counterfeiting of medicines and the selling of unsafe drugs should be subject to tough civil and criminal penalties.


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.